"T cell-dependent bispecific antibodies induce adverse systemic changes in addition to tumor killing. This study shows how different vascular beds respond to cancer immunotherapy, suggesting that reducing leukocyte-endothelial interactions may limit the accumulation of T cells, thereby alleviating off-tumor adverse responses."
Himmels et al @emboreports
#immunology #immunotherapy #BispecificAntibody